BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 1766669)

  • 1. Repression of the chicken c-rel promoter by vRel in chicken embryo fibroblasts is not mediated through a consensus NF-kappa B binding site.
    Capobianco AJ; Gilmore TD
    Oncogene; 1991 Dec; 6(12):2203-10. PubMed ID: 1766669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. rel/NF-kappa B nuclear complexes that bind kB sites in the murine c-rel promoter are required for constitutive c-rel transcription in B-cells.
    Grumont RJ; Richardson IB; Gaff C; Gerondakis S
    Cell Growth Differ; 1993 Sep; 4(9):731-43. PubMed ID: 8241021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The v-Rel oncoprotein increases expression from Sp1 site-containing promoters in chicken embryo fibroblasts.
    Sif S; Capobianco AJ; Gilmore TD
    Oncogene; 1993 Sep; 8(9):2501-9. PubMed ID: 8361761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the rel-homology domain alter the biochemical properties of v-rel and render it transformation defective in chicken embryo fibroblasts.
    Morrison LE; Boehmelt G; Enrietto PJ
    Oncogene; 1992 Jun; 7(6):1137-47. PubMed ID: 1594245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and autoregulation of the c-rel promoter.
    Hannink M; Temin HM
    Oncogene; 1990 Dec; 5(12):1843-50. PubMed ID: 2284104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and expression of a chicken c-rel cDNA: unlike p59v-rel, p68c-rel is a cytoplasmic protein in chicken embryo fibroblasts.
    Capobianco AJ; Simmons DL; Gilmore TD
    Oncogene; 1990 Mar; 5(3):257-65. PubMed ID: 2179815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of tumor necrosis factor alpha-responsive serine residues within the C-terminal transactivation domain of human transcription factor REL enhance its in vitro transforming ability.
    Starczynowski DT; Reynolds JG; Gilmore TD
    Oncogene; 2005 Nov; 24(49):7355-68. PubMed ID: 16027730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A yeast transcription assay defines distinct rel and dorsal DNA recognition sequences.
    Kamens J; Brent R
    New Biol; 1991 Oct; 3(10):1005-13. PubMed ID: 1768648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformation by the vRel oncoprotein requires sequences carboxy-terminal to the Rel homology domain.
    Sarkar S; Gilmore TD
    Oncogene; 1993 Aug; 8(8):2245-52. PubMed ID: 8336947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the promoter region of the c-yes proto-oncogene: the importance of the GC boxes on its promoter activity.
    Matsuzawa Y; Semba K; Kawamura-Tsuzuku J; Sudo T; Ishii S; Toyoshima K; Yamamoto T
    Oncogene; 1991 Sep; 6(9):1561-7. PubMed ID: 1923523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperation of binding sites for STAT6 and NF kappa B/rel in the IL-4-induced up-regulation of the human IgE germline promoter.
    Messner B; Stütz AM; Albrecht B; Peiritsch S; Woisetschläger M
    J Immunol; 1997 Oct; 159(7):3330-7. PubMed ID: 9317131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL.
    Cogswell PC; Scheinman RI; Baldwin AS
    J Immunol; 1993 Apr; 150(7):2794-804. PubMed ID: 8454856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence.
    Mosialos G; Gilmore TD
    Oncogene; 1993 Mar; 8(3):721-30. PubMed ID: 8437855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity.
    Starczynowski DT; Trautmann H; Pott C; Harder L; Arnold N; Africa JA; Leeman JR; Siebert R; Gilmore TD
    Oncogene; 2007 Apr; 26(19):2685-94. PubMed ID: 17072339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. v-rel- and c-rel-protein complexes bind to the NF-kappa B site in vitro.
    Kochel T; Rice NR
    Oncogene; 1992 Mar; 7(3):567-72. PubMed ID: 1549370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcineurin activates transcription from the GM-CSF promoter in synergy with either protein kinase C or NF-kappa B/AP-1 in T cells.
    Tsuboi A; Muramatsu M; Tsutsumi A; Arai K; Arai N
    Biochem Biophys Res Commun; 1994 Mar; 199(2):1064-72. PubMed ID: 8135780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional synergism of STAT6 with either NF-kappa B or PU.1 to mediate IL-4-induced activation of IgE germline gene transcription.
    Stütz AM; Woisetschläger M
    J Immunol; 1999 Oct; 163(8):4383-91. PubMed ID: 10510379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between proto-oncoprotein Rel and TATA-binding protein mediates transcriptional activation by NF-kappa B.
    Kerr LD; Ransone LJ; Wamsley P; Schmitt MJ; Boyer TG; Zhou Q; Berk AJ; Verma IM
    Nature; 1993 Sep; 365(6445):412-9. PubMed ID: 8413585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolutionarily conserved sequence upstream of the human Ig heavy chain S gamma 3 region is an inducible promoter: synergistic activation by CD40 ligand and IL-4 via cooperative NF-kappa B and STAT-6 binding sites.
    Schaffer A; Cerutti A; Shah S; Zan H; Casali P
    J Immunol; 1999 May; 162(9):5327-36. PubMed ID: 10228008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A conditional mutant of vRel containing sequences from the human estrogen receptor.
    Capobianco AJ; Gilmore TD
    Virology; 1993 Mar; 193(1):160-70. PubMed ID: 8438564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.